Connect, Biopharmaceuticals

Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4R?, Into Clinical Development

22.06.2018 - 12:21:48

Connect Biopharmaceuticals, Ltd. China Australia

@ prnewswire.co.uk